ChEBI

CHEBI:144818 - α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide

ChEBI Name α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide ChEBI ID CHEBI:144818 ChEBI ASCII Name alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-[alpha-D-galactosyl-(1->3)-[alpha-L-fucosyl-(1->2)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->6)]-beta-D-galactosyl-(1->4)-N-acetyl-beta-D-glucosaminyl-(1->3)-beta-D-galactosyl-(1->4)-beta-D-glucosyl-(1<->1')-ceramide Stars This entity has been manually annotated by a third party. Submitter Lucila Aimo Download Molfile XML SDF Find compounds which contain this structure Find compounds which resemble this structure Take structure to the Advanced Search Formula C82H136N4O61R2 Net Charge 0 Average Mass (excl. R groups) 2153.951 Monoisotopic Mass (excl. R groups) 2152.76629 SMILES [C@@H]1([C@@H]([C@H]([C@H]([C@H](O1)CO)O)O[C@H]2[C@@H]([C@H]([C@@H]([C@H](O2)CO)O[C@H]3[C@@H]([C@H]([C@H]([C@H](O3)CO[C@H]4[C@@H]([C@H]([C@@H]([C@H](O4)CO)O[C@H]5[C@@H]([C@H]([C@H]([C@H](O5)CO)O)O[C@@H]6[C@@H]([C@H]([C@H]([C@H](O6)CO)O)O)O)O[C@H]7[C@H]([C@@H]([C@@H]([C@@H](O7)C)O)O)O)O)NC(=O)C)O)O[C@H]8[C@@H]([C@H]([C@@H]([C@H](O8)CO)O[C@H]9[C@@H]([C@H]([C@H]([C@H](O9)CO)O)O[C@@H]%10[C@@H]([C@H]([C@H]([C@H](O%10)CO)O)O)O)O[C@H]%11[C@H]([C@@H]([C@@H]([C@@H](O%11)C)O)O)O)O)NC(=O)C)O)O)NC(=O)C)O)O[C@H]%12[C@@H]([C@H]([C@@H](O[C@@H]%12CO)OC[C@@H]([C@@H](*)O)NC(=O)*)O)O ChEBI Ontology Outgoing α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide (CHEBI:144818) has functional parent α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide (CHEBI:144678) α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide (CHEBI:144818) is a glycododecaosylceramide (CHEBI:62308) α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide (CHEBI:144818) is a organic molecular entity (CHEBI:50860) Incoming α-D-Gal-(1→3)-[α-L-Fuc-(1→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-[α-D-Gal-(1→3)-[α-L-Fuc-(1→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-Cer (CHEBI:90155) is a α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-[α-D-galactosyl-(1→3)-[α-L-fucosyl-(1→2)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→6)]-β-D-galactosyl-(1→4)-N-acetyl-β-D-glucosaminyl-(1→3)-β-D-galactosyl-(1→4)-β-D-glucosyl-(1↔1ʼ)-ceramide (CHEBI:144818) Synonyms Sources a neolactoside VI3-α-Gal,VI2-α-Fuc,IV6-[Gal-α-(1→3)-(Fuc-α-(1→2))-Gal-β-(1→4)-GlcNAc]-nLc6Cer UniProt α-D-Gal-(1→3)-[α-L-Fuc-(1→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-[α-D-Gal-(1→3)-[α-L-Fuc-(1→2)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→6)]-β-D-Gal-(1→4)-β-D-GlcNAc-(1→3)-β-D-Gal-(1→4)-β-D-Glc-(1↔1ʼ)-Cer SUBMITTER blood antigen group type III B SUBMITTER Citation Type Source 6510415 PubMed citation SUBMITTER